Home›Companies›Biotech & Pharma›Oligomerix

Oligomerix, Inc.

Updated Oct 29, 2026·Latest SEC filing Dec 6, 2024·Suggest an edit

About Oligomerix

Oligomerix is a private company based in White Plains, New York. It has reported $2,915,568 raised in five offerings on Form D since March 2012. Its chief executive is James Moe.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 25, 2024Dec 6, 2024$75,000of $650K target3$25,000DebtRule 506(b)Form D ↗
Mar 24, 2022Mar 29, 2022$2,440,568of $3.5M target12$203KEquity, OptionsRule 506(b)Form D ↗
Apr 3, 2015Apr 15, 2015$400,000of $3.0M target2$200KEquity, OptionsRule 506(b)Form D ↗
Not yetFeb 14, 2013$0of $2.8M target0—Equity, Options06Form D ↗
Not yetMar 20, 2012$0of $2.7M target0—Equity06Form D ↗
Total, five offerings$2,915,568

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Oligomerix's Form D filed Dec 6, 2024.

DD
WE
William Erhardt
Executive officer and director
RF
Robert Foerster
Executive officer and director
ED
Eliot Davidowitz
Executive officer and director
JM
James Moe
CEO and director
DD
JP
Jack Pasini
Executive officer and director

Earlier filings also listed Victor Micati (director, last listed Mar 2022) and Robert Forester (executive officer, last listed Mar 2022).

Sources

  1. SECOligomerix, Inc. filing history